these changes were compared with values found during lesion resolution with other therapies used in psoriasis , i.e . topical dithranol , puva , oral etretinate and hydroxyurea and were highly reminiscent of those observed during puva therapy but contrasted with those during etretinate treatment .
C0033860
psoriasis
C0015137
etretinate